Kenya's MYDAWA secures US$3-million in funding

Kenya's MYDAWA secures US$3-million in funding

Operators of e-health platform plan to use funds to support local expansion.

Kenya's e-health platform MYDAWA has secured a US$3-million from the Africa Healthcare Master Fund to support its local expansion.

The company is believed to have sold an undisclosed minority stake and stated: "The funds will go into accelerating a planned countrywide expansion and further advance the company's overall vision of providing access to affordable, genuine and high-quality medicine as well as health care products."

MYDAWA verifies doctor's prescriptions before medication is dispensed to the patient.

Medicines are delivered through trusted partner pharmacy outlets and qualified pharmtechs licensed by the PPB (Pharmacy & Poisons Board) and members of the Kenya Pharmaceutical Association (KPA).

According to MYDAWA it has a user base of over 80,000.

Customers can also verify the authenticity of medicines through scanning of a QR Code or using SMS.

"Our goal at MYDAWA has always been to be trusted partner for busy Kenyans by providing convenient, private access to authentic medication and wellness products at very good value. It was very important that a new partner shared this goal which is inspired by the Kenyan aim of improving access to healthcare for all," stated Neil O'Leary, Founder and Chairman of MYDAWA.

MYDAWA Managing Director Tony Wood said, "We remain focused on building a platform that enables Kenyans to access quality medication and products without having to dig deeper into their pockets".

The total pharmaceutical and medical devices market in Kenya is over US$1-billion by this year, according to the company.

The company's work is in tandem with Kenya's e-health strategy, formulated by the government that aims to fully integrate the use of ICT in the health sector by the year 2030.